Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Marianne A. van de Pol is active.

Publication


Featured researches published by Marianne A. van de Pol.


COPD: Journal of Chronic Obstructive Pulmonary Disease | 2007

Repeatability of Inflammatory Parameters in Induced Sputum of COPD Patients

Martin Boorsma; Rene Lutter; Marianne A. van de Pol; Theo A. Out; Henk M. Jansen; René E. Jonkers

Rationale: Limited information is available on repeatability of inflammatory parameters in whole induced sputum samples from patients with COPD. Objectives: To study short-term and long-term repeatability in induced sputum samples in 22 patients with moderate to severe, stable COPD (mean age 64 yr, mean FEV1 1.91 L = 65% of predicted). Samples were collected on 71 occasions twice within 1 to 7 days (mean 3.8 days) and on 12 occasions twice with an interval of 3 months while clinically stable. Cell differentials, markers of neutrophilic and eosinophilic inflammation, respiratory membrane permeability and size-selective permeation were assessed. Findings: Parameters of permeability and of size-selective permeation, % eosinophils and % neutrophils showed the best short-term repeatability with intra-class correlation coefficients (Ri) of 0.61 to 0.90, followed by total cell count (TCC) with Ri of 0.52. Repeatability of soluble cell activation markers was less satisfactory (Ri 0.34 to 0.52). Mean short-term within-patient variability for TCC and permeability was approximately 2-fold and for cell activation markers 3-fold; mean between-patients variability was twice as high. Inducing sputum slightly enhanced eosinophil numbers and % neutrophils and decreased % macrophages in successive IS samples. Long-term repeatability was comparable to short-term repeatability but variability increased. Conclusions: Repeatability of parameters assessed in whole sputum is similar as reported previously for sputum plugs. In COPD an induced sputum procedure has a minor pro-inflammatory effect. The current data facilitates power calculations but also indicates that studies using inflammatory markers in sputum may easily be underpowered.


Thorax | 2013

Systemic tryptophan and kynurenine catabolite levels relate to severity of rhinovirus-induced asthma exacerbation: a prospective study with a parallel-group design

Koenraad F. van der Sluijs; Marianne A. van de Pol; Wim Kulik; Annemiek Dijkhuis; B. S. Smids; Hetty van Eijk; Jos A Karlas; Richard Molenkamp; Katja C. Wolthers; Sebastian L. Johnston; Jaring S. van der Zee; Peter J. Sterk; Rene Lutter

Background Patients with allergic asthma have exacerbations which are frequently caused by rhinovirus infection. The antiviral tryptophan-catabolising enzyme indoleamine 2,3-dioxygenase (IDO) is induced by interferon-γ and suppressed by Th2 mediators interleukin (IL)-4 and IL-13. We hypothesised that local IDO activity after viral airway infection is lower in patients with allergic asthma than in healthy controls. Objective To determine whether IDO activity differs between patients with allergic asthma and healthy individuals before and after rhinovirus infection. Methods Healthy individuals and patients with allergic asthma were experimentally infected with low-dose (10 TCID50) rhinovirus 16. Blood, bronchoalveolar lavage fluid and exhaled breath condensate (for mass spectrometry by UPLC-MS/MS) were obtained before and after rhinovirus challenge. Results IDO activity was not induced by rhinovirus infection in either group, despite increases in cold scores. However, baseline pulmonary IDO activity was lower in patients with allergic asthma than in healthy individuals. In contrast, systemic tryptophan and its catabolites were markedly higher in patients with allergic asthma. Moreover, systemic quinolinic acid and tryptophan were associated with eosinophil cationic protein (r=0.43 and r=0.78, respectively) and eosinophils (r=0.38 and r=0.58, respectively) in bronchoalveolar lavage fluid and peak asthma symptom scores after rhinovirus challenge (r=0.53 and r=0.64, respectively). Conclusions Rhinovirus infection by itself induces no IDO activity, but the reduced pulmonary IDO activity in patients with allergic asthma at baseline may underlie a reduced control of viral infections. Notably, the enhanced systemic catabolism of tryptophan in patients with allergic asthma was strongly related to the outcome of rhinovirus challenge in asthma and may serve as a prognostic factor.


Allergy | 2015

Allergic sensitization is associated with inadequate antioxidant responses in mice and men.

L. Utsch; Caterina Folisi; Jaap H. Akkerdaas; Adrian Logiantara; Marianne A. van de Pol; Jaring S. van der Zee; Esmeralda Krop; Rene Lutter; Ronald van Ree; Leonie S. van Rijt

Allergies arise from aberrant Th2 responses to allergens. The processes involved in the genesis of allergic sensitization remain elusive. Some allergens such as derived from house dust mites have proteolytic activity which can induce oxidative stress in vivo. A reduced capacity of the host to control oxidative stress might prime for allergic sensitization.


Respiratory Research | 2014

Evaluation of coagulation activation after rhinovirus infection in patients with asthma and healthy control subjects: an observational study

Christof J. Majoor; Marianne A. van de Pol; Pieter Willem Kamphuisen; Joost C. M. Meijers; Richard Molenkamp; Katja C. Wolthers; Tom van der Poll; Rienk Nieuwland; Sebastian L. Johnston; Peter J. Sterk; Elisabeth H. Bel; Rene Lutter; Koenraad F. van der Sluijs


American Journal of Respiratory and Critical Care Medicine | 2015

Electronic nose identifies bronchoalveolar lavage fluid eosinophils in asthma.

Niki Fens; Koenraad F. van der Sluijs; Marianne A. van de Pol; Annemiek Dijkhuis; B. S. Smids; Jaring S. van der Zee; Rene Lutter; Aeilko H. Zwinderman; Peter J. Sterk


American Journal of Respiratory and Critical Care Medicine | 2018

Anti-IL5 in Mild Asthma Alters Rhinovirus-Induced Macrophage, B Cell and Neutrophil Responses (MATERIAL): A Placebo-Controlled, Double-Blind Study

Yanaika Sabogal Pineros; Suzanne M. Bal; Marianne A. van de Pol; Barbara S. Dierdorp; Tamara Dekker; Annemiek Dijkhuis; Paul Brinkman; Koen van der Sluijs; Aeilko H. Zwinderman; Christof J. Majoor; Peter I. Bonta; Lara Ravanetti; Peter J. Sterk; Rene Lutter


European Respiratory Journal | 2016

Identification of exhaled volatile organic compounds (VOCs) associated with loss of asthma control

Paul Brinkman; Niki Fens; Marianne A. van de Pol; Peter J. Sterk; Anirban Sinha


European Respiratory Journal | 2016

LSC Abstract – Identifying biomarkers of loss of control/exacerbations in asthma from exhaled breath

Paul Brinkman; Sinha Anirban; Marianne A. van de Pol; Niki Fens; Peter J. Sterk; Marije G. Gerritsen


European Respiratory Journal | 2015

Longitudinal changes in exhaled breath GC/MS profiles during loss of asthma control by prospective steroid withdrawal

Paul Brinkman; Marianne A. van de Pol; Aeilko H. Zwinderman; Peter J. Sterk; Niki Fens


European Respiratory Journal | 2014

Systemic coagulation increases with asthma severity

Marlous Sneeboer; Christof J. Majoor; Niki Fens; Marianne A. van de Pol; Koen van der Sluijs; Joost C. M. Meijers; Pieter-Willem Kamphuisen; Rene Lutter; Peter J. Sterk; Elisabeth H. Bel

Collaboration


Dive into the Marianne A. van de Pol's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Rene Lutter

University of Amsterdam

View shared research outputs
Top Co-Authors

Avatar

Niki Fens

University of Amsterdam

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Sebastian L. Johnston

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge